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Background: Patients with Tuberculosis (TB) are a vulnerable group for acquiring HIV infection. Therefore, countries
with a concentrated HIV epidemic and high prevalence of TB should provide adequate information about HIV
prevention to TB patients.
Methods: We conducted a cross-sectional study to evaluate the level of knowledge on HIV prevention and transmission
among newly diagnosed TB patients in Lima, Peru. The survey evaluated knowledge about HIV infection and prevention
and was administered before HIV counseling and blood sampling for HIV testing were performed.
Results: A total of 171 TB patients were enrolled; mean age was 31.1 years, 101 (59%) were male. The overall mean
level of knowledge of HIV was 59%; but the specific mean level of knowledge on HIV transmission and prevention
was only 33.3% and 41.5%, respectively. Age and level of education correlated with overall level of knowledge in
the multivariate model (P-value: 0.02 and <0.001 respectively).
Conclusions: The study shows inadequate levels of knowledge about HIV transmission and prevention among
newly-diagnosed TB patients in this setting, and underscores the need for implementing educational interventions
in this population.
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In 2011, the global number of new tuberculosis (TB) cases
was 8.7 million; 13% of these cases were co-infected with
the human immune deficiency virus (HIV), and only 40%
of TB notified cases were tested for HIV [1]. Peru reported
an incidence of pulmonary TB of 101 cases per 100 000 ha-
bitants in 2011, based on the WHO Global Tuberculosis
Control report of 2012 [1]. Based on the same report,
only 21% of all Peruvian TB patients knew their HIV status
(14% were HIV positive) [1]. TB is specially concentrated in
urban areas in Peru, where the capital city, Lima, houses
58% of TB cases [2]. The HIV situation in Peru is that of a
concentrated epidemic [3]. Lima reports the highest inci-
dence rate of HIV infection in the country [4,5], creating a
favorable scenario for the co-infection of HIV and TB. In* Correspondence: cesar.ugarte@upch.pe
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reproduction in any medium, provided the orfact, since the beginning of the HIV epidemic in Peru, TB
has been recognized as a significant cause of morbidity and
mortality among HIV-infected patients [6,7].
An essential component of the Global Plan to Stop TB
2011–2015 is to empower TB patients, pursuing advo-
cacy, communication, and community participation in
health care and prevention [8]. Integration of TB and
HIV activities at the community health level is also es-
sential to reach the pre-specified goals for 2015. To im-
plement HIV prevention strategies among TB patients it
is essential to know the level of knowledge about HIV in
this specific population. Several studies [9-12] have eval-
uated the level of HIV knowledge in different Peruvian
populations, and some of these studies have addressed
vulnerable populations [10], but there is no information
available on this topic in TB patients in Peru.
We conducted this study to evaluate the level of know-
ledge about HIV among newly diagnosed TB patients in
the district of San Juan de Lurigancho, the most denselyral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mately 1 million inhabitants living within a surface area
of 131.21 km2. In 2010, this district of Lima reported




We conducted a cross-sectional study, from October
2010 to November 2011, among adult patients recently
diagnosed with pulmonary TB, confirmed by micros-
copy and/or culture, with no previous diagnosis of HIV
infection, at peripheral health care centres of San Juan
de Lurigancho district in Lima, Peru. There are over 30
peripheral health care centres in this district; every centre
has an office from the National TB Program (NTP) to
provide directly observed therapy (DOT).
Questionnaire
The instrument to measure knowledge about HIV was a
self-administered questionnaire containing 11 questions
about socio-demographic information, TB history, previous
HIV tests and 17 multiple-choice questions about know-
ledge of HIV infection, transmission and prevention. The
maximum score for HIV knowledge was 35 points, reflect-
ing 100% overall level of knowledge. This instrument has
been applied before in a similar population in Lima [9], but
was validated again with a pilot study before using it in this
study population (Chronbach’s alpha (0.6)).
Data analysis
Since HIV counseling is mandatory before testing, the
questionnaire was applied before counseling and blood
sampling for HIV testing were performed. Considering a
confidence level of 95%, a power of 80% and a level of
knowledge of 60-70% (based on previous studies) [9-12],
the minimum sample size was 171 participants. To reach
a better representative sample, the sample size by each
center was weighted by the number of TB patients seen
by these centers in 2009. A convenience sampling was used
until each center reached its sample size.
Data were entered in Microsoft Access 2007 database
(Microsoft, US) and was analysed using STATA v12.0
(StataCorp, US). Mean differences in the level of knowledge
across demographic groups, socio-economic groups and
level of education were evaluated. A backward stepwise lin-
ear regression model was used to evaluate the association
between level of knowledge (percentage of correct answers
on the questionnaire) and predictor variables. A 0.05 level
of significance was used throughout.
Ethical considerations
All participants gave signed consent to participate in the
study. The Institutional Review Board from UniversidadPeruana Cayetano Heredia and the Health Direction of
San Juan de Lurigancho district approved the study.
Results
A total of 171 participants were interviewed. The mean age
was 31.1 years (median age was 26), 101(59%) were males,
15 (8.8%) had a previous TB episode and 44 (25.7%) had
a previous HIV test (all negative). Males had more sexual
partners and a higher proportion of reported use of
condoms compared with females. Other characteristics
of the participants are presented in Table 1.
The mean percent correct answers regarding knowledge
on HIV was 59% (SD: 15.7). None of the participants
obtained the 100% level of knowledge (min: 22.9%; max:
97.1%). Only 33.3% and 41.5% had correct answers regard-
ing knowledge of ways for HIV transmission and know-
ledge of preventive practices, respectively. A total of 83
participants (48.5%) considered that the condom should
be used always for vaginal, anal and oral sex, but only
55 participants (32.2%) reported regular condom use.
The overall level of knowledge increased by education
level: 45.2% for participants who completed primary school
level, 57.8% for participants who completed secondary
school level, and 68.6% for participants with greater than
secondary school education. Women had a higher level
of knowledge (mean: 61.3%; SD: 15.5) compared with men
(mean: 57.4%; SD: 15.7).
The univariate analysis is presented in Table 2. Only edu-
cation level and age showed significant association with
overall level of knowledge. Mean level of knowledge was
associated positively with education, with an increase of
11.6 percentage points (95% CI: 8.1- 15.0; p-value < 0.001)
by each level of education. However, it was associated
negatively with age in the group older than 26 years,
decreasing by 1.33 percentage points per year of age
(95% CI: -2.43 - -0.22; p-value = 0.02). Age younger than
26 years old, gender, single status, previous TB episode
and number of sexual partners did not show statisti-
cally significant correlation with level of knowledge.
The multivariate regression model is shown in Table 3
and included age older than 26 years and level of educa-
tion, showing a decrease in the level of knowledge with
older age (0.25 percentage points mean decrease per 1
year increase in age, p-value = 0.01), and an increase in the
mean level of knowledge with higher level of education
(mean increase 10.6 percentage points, p-value < 0.001).
Discussion
This study found a low level of knowledge about HIV trans-
mission and prevention among newly diagnosed TB pa-
tients in San Juan de Lurigancho. This main finding of the
study, taken into account along with the low percentage of
regular condom use in TB patients puts this population at
risk to acquire HIV and other sexually transmitted diseases.
Table 1 Characteristics of the study population
Characteristics Total (n = 171) Male (n = 101) Female (n = 70) P- value**
Mean age (SD) 31.1 (13) 30.7 (13.2) 31.5 (12.8) 0.7
Marital status
Single (%) 104 (60.8%) 69 (68.3%) 35 (70%) 0.8
Level of education
Primary school (%) 23 (13.5%) 14 (13.9%) 9 (12.9%) 0.9
Secondary school (%) 103 (60.2%) 66 (65.4%) 37 (52.9%) 0.2
Above secondary school (%) 45 (26.3%) 21 (20.8%) 24 (34.3%) 0.3
Previous TB episode (%) 15 (8.8%) 4 (5.7%) 11 (10.9%) 0.2
Median number of sexual partners (Range) 1 (0–21) 2 (0–21) 1 (0–10) <0.001
Reported use of condoms (%) 70 (40.9%) 36 (35.6%) 19 (27.1%) 0.2
Mean level of knowledge, % (SD)* 59 (15.7) 57.4 (15.7) 61.3 (15.5) 0.11
*Highest possible level of knowledge is 100% = 35 points.
**Comparison between males and females; t-test for difference of means, Man-Whitney for medians and chi-square for difference in proportions.
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be pointed out. First, we observed a decrease in the level
of knowledge on HIV transmission and prevention by age.
This finding can be explained by a “cohort effect” [14].
Younger participants had more access to and had higher
chances of receiving education on this topic compared
with older participants. At the beginning of the HIV epi-
demic in the 1980s and early 1990s, information about
HIV prevention was not widely available for all, therefore,
youth at that time were unlikely to be exposed to adequate
information for HIV prevention. However, despite more
opportunities to exposure to HIV prevention information
among younger populations in Peru, the reported median
age of HIV infection is around 20 years old in Peru [15].
Second, an increase in the level of knowledge was ob-
served with level of education in this study. A systematic
review showed that most educated people had a lower risk
of HIV infection. This review found that the HIV preva-
lence dropped more consistently in this group compared
with less educated people [16].
Some studies have shown the importance of offering
HIV counseling to TB patients [16,17]. HIV testing was of-
fered to all TB patients in the study area for free. However,




Age < 26 years old 0.85 −0.1 – 1.8 0.08
Age > 26 years old −1.32 −2.4 – –0.2 0.02
Single −1.1 −3.1 – 0.9 0.3
Male −3.9 −8.7 – 0.9 0.1
Previous TB episode 1.13 −7.3 – 9.5 0.8
Number of sexual partners −0.35 −1.3 – 0.5 0.4
Education 11.5 8.1 – 15 <0.001known HIV status has been decreasing over recent years
(35%, 29% and 21% for 2009, 2010 and 2011, respectively)
[1]. The NTP provides regular preventing activities for TB
among TB patients and their relatives, but it is necessary
to implement more collaborative activities between the NTP
and HIV programs, to improve the detection and prevention
of HIV infection among TB patients at a national level.
WHO remarks the importance of the integration of
both programs in prevention and treatment [18], espe-
cially in settings with limited resources. For example,
experiences in Malawi and South Africa showed that
local integrated programs could operate successfully
[19]. One systematic review showed that the referral model
(where TB patients are referred to HIV service for HIV
diagnosis, and vice versa) could be the less complex
model, but still have the risk of failure in the referral
process (the patient does not attend the appointment
for several factors) [20]. The referral model is currently
in place in Peru. The lower cost of this model compared
to a fully-integrated model is a potential advantage, but it
has to be weighted against the big weakness of losing refer-
rals (only 21% of TB patients know their HIV status in Peru
despite of free access). There is also a lack of information of
programmatic and logistic issues of integrated TB-HIV ser-
vices in settings without high HIV prevalence such as Peru
(most of the studies are based in African countries) [21-23].
As the evidence shows, the integration of these programs
cannot be performed with a unique recipe for all settings.
The importance of HIV testing and counseling is not
only to promptly identify HIV infected patients, but alsoTable 3 Multivariate regression model
Variables Regression coefficient 95% CI P-value
Age > 26 years old −0.25 −0.44 – –0.06 0.01
Education 10.63 7.2 – 14.1 <0.001
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[24]. In the case of TB patients in Peru, because they
are a generally young population and share similar
demographic characteristics with vulnerable populations
for HIV infection, HIV counseling and testing activities
at the time of TB testing can provide the opportunity
to address the potential lack of HIV knowledge among
these vulnerable populations.
Some public health programs (such as NTP or pregnancy
program) in Peru provide free HIV counseling and free
HIV testing to benefit their patients as described before. In
recent years, the Peruvian Government, non-governmental
organizations, academic institutions, and international ini-
tiatives, such as the Global Fund have developed activities
to provide information about HIV prevention to different
populations in the country [14]. As a result of these and
other initiatives, the level of knowledge on HIV prevention
among women increased from 18.9% in 2000 to 68.2% in
2011, based on information from the National Survey for
Demography and Family Health (ENDES 2011) [25].
Other studies have shown a similar level of knowledge
as in our study among people seeking HIV counseling in
a referral hospital in Lima [9]. However, a comparison of
these studies with the information provided in our study
is difficult to make. Reasons for that include different
questionnaires used to evaluate level of knowledge and
no detailed evaluation of factors associated with the level
of knowledge in these studies [10-12,25]. At a more glo-
bal level, there is a lack of information about the level of
HIV knowledge among TB patients. One study in China
reported only 1.7% level of knowledge about HIV among
2300 TB patients [26], and another study in Afghanistan
showed that 23.3% of tuberculosis patients knew about
HIV [27]. No studies on this topic are available from
Latin America.
This study has several limitations; one of these is se-
lection bias. Efforts were made to minimize this bias
using intensive enrolment of study subjects during TB
clinic attention hours. In addition, HIV carries a stigma
in our population, and some of the questions, especially the
questions regarding sexual practices, may be affected by in-
formation bias (specifically recall bias). Another limitation
of this and other similar studies is the lack of a standardized
tool for evaluating level of HIV knowledge, which makes
comparison across studies difficult.
Conclusion
After more than 25 years since the first case of HIV in
Peru, there is still lack of knowledge on HIV prevention
in the TB infected population. Although Peru does not
have an HIV/TB problem of the same magnitude as
Sub-Saharan African countries, our results indicate that it
is necessary to put more efforts towards HIV prevention
among this population. Specific interventions directed atTB patients, implemented in coordination between HIV
and TB programs, are necessary to address this issue.
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